Charles Maxwell-Armstrong Selected Research

105AD7 antibody

12/2006

A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles Maxwell-Armstrong Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 12/2006
2	Colorectal Neoplasms (Colorectal Cancer) 12/2006 - 09/2002
1	Ovarian Neoplasms (Ovarian Cancer) 06/2022
1	Wound Infection (Wound Infections) 01/2016
1	Cutaneous Fistula 01/2016
1	Pain (Aches) 07/2013
1	Abdominal Abscess 04/2012
1	Necrosis 04/2012

Drug/Important Bio-Agent (IBA)

1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Opioid Analgesics (Opioids)IBA 07/2013
1	Prednisolone (Predate)FDA LinkGeneric 04/2012
1	Adalimumab (Humira)FDA Link 04/2012
1	Complement System Proteins (Complement)IBA 12/2006
1	aluminum sulfate (alum)IBA 12/2006
1	CD55 Antigens (Decay Accelerating Factor)IBA 12/2006
1	Glycoproteins (Glycoprotein)IBA 12/2006
1	105AD7 antibodyIBA 12/2006
1	Monoclonal AntibodiesIBA 09/2002
1	AntigensIBA 09/2002

Therapy/Procedure

2	Cytoreduction Surgical Procedures 06/2022 - 01/2022
1	Debridement 01/2016
1	Length of Stay 07/2013
1	Therapeutics 04/2012
1	Immunotherapy 09/2002